1 – 20 of 22
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Impact on follow-up strategies in patients with primary sclerosing cholangitis
(
- Contribution to journal › Article
- 2022
-
Mark
Development of a prognostic MRCP score (DiStrict) for patients with large-duct primary sclerosing cholangitis
(
- Contribution to journal › Article
-
Mark
Development of a novel MRCP-score for patients with primary sclerosing cholangitis, and assessment of agreement and prognostic value
(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
(
- Contribution to journal › Article
- 2017
-
Mark
Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis
(
- Contribution to journal › Article
-
Mark
Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis
(
- Contribution to journal › Article
-
Mark
Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers
(
- Contribution to journal › Article
- 2016
-
Mark
Pregnancy and childbirth in women with autoimmune hepatitis is safe, even in compensated cirrhosis.
(
- Contribution to journal › Article
- 2015
-
Mark
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients
(
- Contribution to journal › Article
- 2014
-
Mark
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
(
- Contribution to journal › Article
- 2012
-
Mark
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia
(
- Contribution to journal › Article
- 2010
-
Mark
Increased Factor Viii Activity In Portal Vein Thrombosis And Budd-Chiari Syndrome
2010) 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases In Hepatology 52(4). p.1217-1217(
- Contribution to journal › Published meeting abstract
-
Mark
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis.
(
- Contribution to journal › Article
-
Mark
Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response
(
- Contribution to journal › Article
- 2009
-
Mark
High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis
(
- Contribution to journal › Article
-
Mark
Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
(
- Contribution to journal › Article
-
Mark
Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients
(
- Contribution to journal › Article
- 2008
-
Mark
The natural history of small duct primary sclerosing cholangitis
(
- Contribution to journal › Article
-
Mark
Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: A nationwide study
(
- Contribution to journal › Article
-
Mark
Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
(
- Contribution to journal › Article